Specificities of anti-platelet antibodies in multitransfused patients with haemato-oncological disorders

British Journal of Haematology

Volumn 95, Issue 3, 1996, Pages 564-569

  Kurz, Martin ^a   Greinix, Hildegard ^a   Höcker, Paul ^a   Kalhs, Peter ^a   Knöbl, Paul ^a   Mayr, Wolfgang Richard ^a   Pober, Michael ^b   Panzer, Simon ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b 2nd Medical Department   (Austria)

Author keywords

Immunization antiplatelet antibodies specificities; Platelet transfusion; Refractoriness

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 1 ANTIBODY; THROMBOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION;

EID: 0029955013     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1936.x     Document Type: Article

References (33)

1. Andreu, G. & Dewailly, J. (1994) Prevention of HLA Alloimmunization by using leukocyte-depleted components. Leukocyte-Depleted Blood Products (ed. by T. A. Lane and G. Myllylä), pp. 29-40, Karger, Basel.
2. Benda, H., Panzer, S., Kiefel, V., Mannhalter, C., Hinterberger, W., Lechner, K. & Mueller-Eckhardt, C. (1989) Identification of the target platelet glycoprotein in autoimmune thrombocytopenia occurring after allogeneic bone marrow transplanlation. Blut, 58, 151-153.
3. Bishop, J.F., Matthews, J.P., Yuen, K., McGrath, K., Wolf, M.M. & Szer, J. (1992) The definition of refractoriness to platelet transfusions. Transfusion Medicine, 2, 35-41.
4. Bishop, J.F., McGrath, K., Wolf, M.M., Matthews, J.P., DeLuise, T., Holdsworth, R., Yuen K., Veale, M., Whiteside, M.G., Cooper, I.A. & Szer, J. (1988) Clinical factors influencing the efficacy of pooled platelet transfusions. Blood, 71, 383-387.
5. Brand, A., Sintnicolaas, K., Claas, F.H.J. & Eernisse, J.G. (1986) ABH antibodies causing platelet transfusion refractoriness. Transfusion, 26, 463-466.
6. Brand, A., van Leeuwen, A., Eernisse, J.G. & Van Rood, J.J. (1978) Platelet transfusion therapy: optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Blood, 51, 781-788.
7. Brubaker, D.B. & Romine, M. (1987) Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy. American Journal of Hematology, 26, 341-352.
8. Doughty, H.A., Murphy, M.F., Metcalfe, P., Rohatiner, A.Z.S., Lister, T. A. & Waters, A.H. (1994) Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sanguinis, 66, 200-205.
9. Dutcher, J.P., Schiffer, C.A., Aisner, J. & Wiernik, P.H. (1981) Long-term follow-up of patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized. Blood, 58, 1007-1011.
10. Friedberg, R.C. Donnelly, S.F., Boyd, J.C., Gray, L.S. & Mintz, P.D. (1993) Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood, 81, 3428-3434.
11. Godeau, B., Fromont, P., Seror, T., Duedari, N. & Bierling, P. (1992) Platelet alloimminization after multiple transfusions: a prospective study of 50 patients. British Journal of Haematology, 81, 395-400.
12. Gruber, J.A. & O'Neill, G.J. (1992) Frequency of alloimmunization to platelet-specific antigens in multitransfused thrombocytopenic patients. Blood, 80, (Suppl.), 218a.
13. Heal, J.M., Blumberg, N. & Masel, D. (1987) An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood 70, 23-30.
14. Holensteiner, A., Walchshofer, S., Adler, A., Kittl, E.M., Mayr, W.R. & Panzer, S. (1995) Human platelet antigen gene frequencies in the Austrian population. Haemostasis, 25, 133-136.
15. Howard, J.E. & Perkins, H.A. (1978) The natural history of alloimmunization to platelets. Transfusion, 18, 496-503.
16. Kickler, T., Kennedy, S.D. & Braine, H.G. (1990) Alloimmunization to platelet-specific antigens on glycoproteins IIb/IIIa and Ib/IX in multiply transfused thrombocytopenic patients. Transfusion, 30, 622-625.
17. Kiefel, V., Santoso, S., Kaufmann, K. & Mueller-Eckhardt, C. (1991) Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura. British Journal of Haematology, 79, 256-262.
18. Kiefel, V., Santoso, S., Weisheit, M. & Mueller-Eckhardt, C. (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet reactive antibodies. Blood, 70, 1722-1726.
19. McGrath, K., Wolf, M., Bishop, J., Veale, M., Ayberk, H., Szer, J., Cooper, I. & Whiteside, M. (1988) Transient platelet and HLA antibody formation in multitransfused patients with malignancy. British Journal of Haematology, 68, 345-350.
20. Mueller-Eckhardt, C. (1990) Platelet allo- and autoantigens and their clinical implications. Transfusion Medicine in the 1990s (ed. by S. T. Nance), pp. 63-93. American Association of Blood Banks, Arlington, Va.
21. Murphy, M.F., Metcalfe, P., Ord, J., Lister, T.A. & Waters, A.H. (1987) Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions. British Journal of Haematology, 67, 255-260.
22. Murphy, M.F. & Waters, A.H. (1985) Immunological aspects of platelet transfusion. British Journal of Haematology, 60, 409-414.
23. Newman P.J. (1994) Nomenclature of human platelet alloantigens: a problem with the HPA system? Blood, 83, 1447-1451.
24. Novotny, V.M., van Doorn, R., Witvliet, M.D., Claas, F.H. & Brand, A. (1995) Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood, 85, 1736-1741.
25. O'Connell, B., Lee, E.J. & Schiffer, C.A. (1988) The value of 10-minute posttransfusion platelet counts. Transfusion, 28, 66-67.
26. Pamphilon, D.H., Farrell, D.H., Donaldson, C., Raymond, P.A., Brady, C.A. & Bradley, P.A. (1989) Development of lymphocytotoxic and platelet reactive antibodies: a prospective study in patients with acute leukemia. Vox Sanguinis, 57, 177-81.
27. Panzer, S., Auerbach, L., Fischer, G., Holensteiner, A., Kittl, E.M., Mayr, W.R., Putz, M., Wagenbichler, P. & Walchshofer, S. (1995) Maternal alloimmunization against fetal platelet antigens: a prospective study. British Journal of Haematology, 90, 655-660.
28. Panzer, S., Maier, F., Höcker, P., Mayr, W.R. & Hinterberger, W. (1987) Platelet transfusion: influence of clinical and immunological conditions. Infusionstherapie will Klinische Ernährung, 14, (Suppl. 2), 10-14.
29. Pegels, J.G., Bruynes, E.C.E., Engelfriet, C.P. & von dem Borne, A.E.G.Kr. (1982) Serological studies in patients on platelet- and granulocyte-substitution therapy. British Journal of Haematology, 52, 59-68.
30. Schnaidt, M., Northoff, H. & Wernet, D. (1996) Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haemato-oncologic patients. Transfusion Medicine, 6, 111-114.
31. Simsek, S., Faber, N.M., Bleeker, P.M., Vlekke, A.B.J., Huiskes, E., Goldschmeding, R. & von dem Borne, A.E.G.Kr. (1995) Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis. Blood, 81, 835-840.
32. Sintnicolaas, K., van Marwijk Kooij, M. van Prooijen, H.C., van Dijk, B.A., van Putten, W.L.J., Claas, F.H.J., Novotny, V.J.M. & Brand, A. (1995) Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study. Blood, 85, 824-828.
33. Slichter, S.J. (1990) Mechanisms and management of platelet refractoriness. Transfusion Medicine in the 1990s (ed. by S. T. Nance), pp. 95-179. American Association of Blood Banks, Arlington, Va.